Related references
Note: Only part of the references are listed.ESM-1 Regulates PI3K-AKT-mTOR Signaling to Promote the Progression of Cervical Cancer
Zhengxia Zhu et al.
ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY (2021)
LncRNAs in ovarian cancer
Jin-yan Wang et al.
CLINICA CHIMICA ACTA (2019)
Repression of Human Papillomavirus Oncogene Expression under Hypoxia Is Mediated by PI3K/mTORC2/AKT Signaling
Felicitas Bossler et al.
MBIO (2019)
Dual Targeting of Y-Box Binding Protein-1 and Akt Inhibits Proliferation and Enhances the Chemosensitivity of Colorectal Cancer Cells
Eva Maier et al.
CANCERS (2019)
PI3K/AKT/mTOR Signaling Regulates the Virus/Host Cell Crosstalk in HPV-Positive Cervical Cancer Cells
Felicitas Bossler et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer
Ying Zeng et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Adipose-Derived VEGF-mTOR Signaling Promotes Endometrial Hyperplasia and Cancer: Implications for Obese Women
Subhransu S. Sahoo et al.
MOLECULAR CANCER RESEARCH (2018)
RAS-related GTPases DIRAS1 and DIRAS2 induce autophagic cancer cell death and are required for autophagy in murine ovarian cancer cells
Margie N. Sutton et al.
AUTOPHAGY (2018)
Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway
Suxian Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
miR-338 modulates proliferation and autophagy by PI3K/AKT/mTOR signaling pathway in cervical cancer
Rong Lu et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway
Chunxiu Dai et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
HPV-16 E7 expression up-regulates phospholipase D activity and promotes rapamycin resistance in a pRB-dependent manner
Tatiana Rabachini et al.
BMC CANCER (2018)
Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis
Xuejing Jin et al.
GENE (2018)
γ-Glutamyl cyclotransferase contributes to tumor progression in high grade serous ovarian cancer by regulating epithelial-mesenchymal transition via activating PI3K/AKT/mTOR pathway
Yanli Li et al.
GYNECOLOGIC ONCOLOGY (2018)
MiR-155-5p inhibits PDK1 and promotes autophagy via the mTOR pathway in cervical cancer
Fang Wang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
Differential Expression of MicroRNAs in Uterine Cervical Cancer and Its Implications in Carcinogenesis; An Integrative Approach
Veena B. Nair et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2018)
IncRNA DLEU1 contributes to tumorigenesis and development of endometrial carcinoma by targeting mTOR
Yuping Du et al.
MOLECULAR CARCINOGENESIS (2018)
PERK/eIF2α signaling inhibits HIF-induced gene expression during the unfolded protein response via YB1-dependent regulation of HIF1α translation
Iglika G. Ivanova et al.
NUCLEIC ACIDS RESEARCH (2018)
Crosstalk between Akt signaling and cold shock proteins in mediating invasive cell phenotypes
Raphael Hohlfeld et al.
Oncotarget (2018)
Cold shock proteins: from cellular mechanisms to pathophysiology and disease
Jonathan A. Lindquist et al.
CELL COMMUNICATION AND SIGNALING (2018)
Long Non-coding RNA DLEU1 Promotes Proliferation and Invasion by Interacting With miR-381 and Enhancing HOXA13 Expression in Cervical Cancer
Chang Liu et al.
FRONTIERS IN GENETICS (2018)
被撤回的出版物: MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR (Retracted article. See vol. 30, pg. 275, 2021)
Suxia Zhang et al.
CANCER BIOMARKERS (2018)
The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapy
Suhu Liu et al.
BLOOD ADVANCES (2018)
Knockdown of lncRNA CCAT2 inhibits endometrial cancer cells growth and metastasis via sponging miR-216b
Pengmu Xie et al.
CANCER BIOMARKERS (2018)
Lean Body Weight and Metformin Are Insufficient to Prevent Endometrial Hyperplasia in Mice Harboring Inactivating Mutations in PTEN
David A. Iglesias et al.
ONCOLOGY (2017)
Box-Binding Protein 1 Promotes Epithelial-Mesenchymal Transition, Invasion, and Metastasis of Cervical Cancer via Enhancing the Expressions of Snail
Tianyun Pang et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)
Targeting glutamine metabolism and the focal adhesion kinase additively inhibits the mammalian target of the rapamycin pathway in spheroid cancer stem-like properties of ovarian clear cell carcinoma in vitro
Masakazu Sato et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
DLEU1 contributes to ovarian carcinoma tumourigenesis and development by interacting with miR-490-3p and altering CDK1 expression
Li-Li Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control
Mariana Lopes Grassi et al.
JOURNAL OF PROTEOMICS (2017)
A Review of mTOR Pathway Inhibitors in Gynecologic Cancer
Andreia Cristina de Melo et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells
Zhihong Zhuo et al.
ONCOTARGET (2017)
Upregulation of the lncRNA Meg3 induces autophagy to inhibit tumorigenesis and progression of epithelial ovarian carcinoma by regulating activity of ATG3
Yin-ling Xiu et al.
ONCOTARGET (2017)
Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells
Ke-yan Cheng et al.
MEDICAL SCIENCE MONITOR (2017)
LncRNA MEG3 has anti-activity effects of cervical cancer
Wang Xiaoguang et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
miR-130a upregulates mTOR pathway by targeting TSC1 and is transactivated by NF-κB in high-grade serous ovarian carcinoma
Yuqiong Wang et al.
CELL DEATH AND DIFFERENTIATION (2017)
LncRNA MEG3 inhibit endometrial carcinoma tumorigenesis and progression through PI3K pathway
Kai-Xuan Sun et al.
APOPTOSIS (2017)
MicroRNAs in gynecological cancers: Small molecules with big implications
Sanjeev K. Srivastava et al.
CANCER LETTERS (2017)
Focal adhesion kinase signaling in unexpected places
Elizabeth G. Kleinschmidt et al.
CURRENT OPINION IN CELL BIOLOGY (2017)
Emerging Role of MicroRNAs in mTOR Signaling
Yanjie Zhang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
p21-activated kinase 4 regulates HIF-1α translation in cancer cells
Hyunju Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Protein Kinase C Isoforms Differentially Regulate Hypoxia-Inducible Factor-1α Accumulation in Cancer Cells
Hyunju Kim et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
Overexpression of GAB2 in ovarian cancer cells promotes tumor growth and angiogenesis by upregulating chemokine expression
C. Duckworth et al.
ONCOGENE (2016)
MiR-634 decreases cell proliferation and induces apoptosis by targeting mTOR signaling pathway in cervical cancer cells
Jianglin Cong et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2016)
A Common Variant at the 14q32 Endometrial Cancer Risk Locus Activates AKT1 through YY1 Binding
Jodie N. Painter et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
Targeting mTOR pathway in gynecological malignancies: Biological rationale and systematic review of published data
Loay Kassem et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Y-box protein-1/p18 as novel serum marker for ovarian cancer diagnosis: A study by the Tumor Bank Ovarian Cancer (TOC)
Irena Rohr et al.
CYTOKINE (2016)
Genetic alterations in endometrial cancer by targeted next-generation sequencing
Ya-Sian Chang et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2016)
Estrogen promotes fat mass and obesity-associated protein nuclear localization and enhances endometrial cancer cell proliferation via the mTOR signaling pathway
Yaping Zhu et al.
ONCOLOGY REPORTS (2016)
Meta-dimensional data integration identifies critical pathways for susceptibility, tumorigenesis and progression of endometrial cancer
Runmin Wei et al.
ONCOTARGET (2016)
Hypoxia-inducible factor 1 alpha is required for the tumourigenic and aggressive phenotype associated with Rab25 expression in ovarian cancer
Natividad Gomez-Roman et al.
ONCOTARGET (2016)
Selective regulation of YB-1 mRNA translation by the mTOR signaling pathway is not mediated by 4E-binding protein
D. N. Lyabin et al.
SCIENTIFIC REPORTS (2016)
Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signaling
Jianjun Han et al.
GYNECOLOGIC ONCOLOGY (2015)
The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses
Lifang Zhang et al.
MOLECULAR CANCER (2015)
Hypoxia-induced MIR155 is a potent autophagy inducer by targeting multiple players in the MTOR pathway
Gang Wan et al.
AUTOPHAGY (2014)
mTOR signaling in tumorigenesis
Kai Xu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)
Molecular Determinants of Outcome With Mammalian Target of Rapamycin Inhibition in Endometrial Cancer
Helen J. Mackay et al.
CANCER (2014)
Relation between outcomes and expression of estrogen receptor-α phosphorylated at Ser167 in endometrioid endometrial cancer
Eiichi Kato et al.
CANCER SCIENCE (2014)
The PPARβ agonist L-165041 promotes VEGF mRNA stabilization in HPV18-harboring HeLa cells through a receptor-independent mechanism
Emmanuelle Roche et al.
CELLULAR SIGNALLING (2014)
Nuclear Y-box-binding protein-1 is a poor prognostic marker and related to epidermal growth factor receptor in uterine cervical cancer
Shin Nishio et al.
GYNECOLOGIC ONCOLOGY (2014)
mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: A critical review
Nader Husseinzadeh et al.
GYNECOLOGIC ONCOLOGY (2014)
Ambivalent role of pFAK-Y397 in serous ovarian cancer- a study of the OVCAD consortium
Stefanie Aust et al.
MOLECULAR CANCER (2014)
miR-99a and-99b inhibit cervical cancer cell proliferation and invasion by targeting mTOR signaling pathway
Li Wang et al.
MEDICAL ONCOLOGY (2014)
Molecular regulation of cervical cancer growth and invasion by VEGFa
Baohuan Chen et al.
TUMOR BIOLOGY (2014)
Growth differentiation factor 15 stimulates rapamycin-sensitive ovarian cancer cell growth and invasion
Samantha E. Griner et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Combined targeting of FGFR2 and mTOR by ponatinib and ridaforolimus results in synergistic antitumor activity in FGFR2 mutant endometrial cancer models
Joseph M. Gozgit et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
MicroRNA-199a-3p Regulates Endometrial Cancer Cell Proliferation by Targeting Mammalian Target of Rapamycin (mTOR)
Dong Wu et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
Absence of Human Papillomavirus Infection and Activation of PI3K-AKT Pathway in Cervical Clear Cell Carcinoma
Sayaka Ueno et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
Targeting Signaling Pathways in Epithelial Ovarian Cancer
Elisabeth Smolle et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer
Zachary C. Dobbin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Sinl phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis
Pengda Liu et al.
NATURE CELL BIOLOGY (2013)
Cancer-Associated Fibroblasts Promote Proliferation of Endometrial Cancer Cells
Kavita S. Subramaniam et al.
PLOS ONE (2013)
microRNA-199a is able to reverse cisplatin resistance in human ovarian cancer cells through the inhibition of mammalian target of rapamycin
Zhongxian Wang et al.
ONCOLOGY LETTERS (2013)
Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma
Anna Torres et al.
BMC CANCER (2012)
CYR61 controls p53 and NF-κB expression through PI3K/Akt/mTOR pathways in carboplatin-induced ovarian cancer cells
Kwang-Beom Lee et al.
CANCER LETTERS (2012)
The PI3K/Akt/mTOR signaling pathway mediates insulin-like growth factor 1-induced E-cadherin down-regulation and cell proliferation in ovarian cancer cells
Man-Tat Lau et al.
CANCER LETTERS (2012)
Biologic rationale and clinical activity of mTOR inhibitors in gynecological cancer
Ivan Diaz-Padilla et al.
CANCER TREATMENT REVIEWS (2012)
A critical role of MYC for transformation of human cells by HPV16 E6E7 and oncogenic HRAS
Mako Narisawa-Saito et al.
CARCINOGENESIS (2012)
mTOR as a Molecular Target in HPV-Associated Oral and Cervical Squamous Carcinomas
Alfredo A. Molinolo et al.
CLINICAL CANCER RESEARCH (2012)
Cold-shock domain family member YB-1 expression in endometrium and endometriosis
C. G. T. Silveira et al.
HUMAN REPRODUCTION (2012)
The mTOR Signalling Pathway in Human Cancer
Helena Populo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Predominance of mTORC1 over mTORC2 in the Regulation of Proliferation of Ovarian Cancer Cells: Therapeutic Implications
Juan Carlos Montero et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Overexpression of Y-box binding protein-1 in cervical cancer and its association with the pathological response rate to chemoradiotherapy
Y. Zhang et al.
MEDICAL ONCOLOGY (2012)
Gab2 regulates the migratory behaviors and E-cadherin expression via activation of the PI3K pathway in ovarian cancer cells
Y. Wang et al.
ONCOGENE (2012)
miR-152 Is a Tumor Suppressor microRNA That Is Silenced by DNA Hypermethylation in Endometrial Cancer
Tomohiko Tsuruta et al.
CANCER RESEARCH (2011)
Up-regulation of Foxp3 inhibits cell proliferation, migration and invasion in epithelial ovarian cancer
Hai-Yan Zhang et al.
CANCER LETTERS (2010)
Localisation of phosphorylated mTOR expression is critical to tumour progression and outcomes in patients with endometrial cancer
Yoshio Yoshida et al.
EUROPEAN JOURNAL OF CANCER (2010)
Activation of mTOR signaling pathway contributes to survival of cervical cancer cells
Jing Ji et al.
GYNECOLOGIC ONCOLOGY (2010)
A Link between mir-100 and FRAP1/mTOR in Clear Cell Ovarian Cancer
Ankur K. Nagaraja et al.
MOLECULAR ENDOCRINOLOGY (2010)
The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer
X. B. Trinh et al.
BRITISH JOURNAL OF CANCER (2009)
Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro
Silvia Darb-Esfahani et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
Elevated phosphatidylinositol 3-kinase activation and its clinicopathological significance in cervical cancer
Xiao-Yan Zhang et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2008)
Activation of mTOR in a subgroup of ovarian carcinomas: Correlation with p-eIF-4E and prognosis
Aurelia Noske et al.
ONCOLOGY REPORTS (2008)
AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth
DA Altomare et al.
ONCOGENE (2004)
Share Paper
